PX1 Research provides reference-grade Selank 10mg lyophilized vials engineered specifically for advanced laboratory research and preclinical investigations. Manufactured in compliant domestic facilities, each batch is thoroughly validated via RP-HPLC and mass spectrometry to ensure strict sequence identity and maximal purity. Researchers can review lot-specific Certificates of Analysis before integration into in vitro or animal models.
PX1 Research provides reference-grade Selank 10mg lyophilized vials engineered specifically for advanced laboratory research and preclinical investigations. Manufactured in compliant domestic facilities, each batch is thoroughly validated via RP-HPLC and mass spectrometry to ensure strict sequence identity and maximal purity. Researchers can review lot-specific Certificates of Analysis before integration into in vitro or animal models.
When evaluating a Selank 10mg shop for analytical and experimental requirements, qualified investigators must prioritize verified molecular purity, lot-specific documentation, and domestic synthesis standards. PX1 Research supplies high-purity Selank 10mg vials manufactured in USA-based facilities, backed by third-party mass spectrometry, RP-HPLC purity assays, and endotoxin verification for reproducible preclinical research.
Choosing an established supplier is critical when acquiring delicate regulatory peptides. Inconsistent synthesis procedures or unverified imports can introduce residual truncated sequences, counter-ions, or bacterial endotoxins that distort experimental outcomes. By reviewing comprehensive documentation in our central research hub, lab technicians and principal investigators can ensure their primary reagents meet strict biochemical criteria before initiating protocols.
Selank is a synthetic heptapeptide with the primary amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was originally designed by the Institute of Molecular Genetics of the Russian Academy of Sciences by combining the sequence of the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with a C-terminal Pro-Gly-Pro tripeptide motif.
The addition of the Pro-Gly-Pro sequence significantly alters the enzymatic stability of the native tuftsin fragment. In native physiological environments, short peptides are rapidly degraded by serum peptidases and carboxypeptidases. Preclinical assays demonstrate that the C-terminal prolyl extension protects the peptide core against enzymatic cleavage, thereby extending its half-life during in vitro and ex vivo tissue culture experiments without sacrificing biological activity.
In preclinical neurochemical models, Selank has been shown to interact with multiple central neurotransmitter systems. Animal studies suggest that the peptide modulates the GABAergic system, specifically altering gamma-aminobutyric acid (GABA) receptor binding affinity and modulating allosteric binding sites. Unlike traditional benzodiazepines, in vitro binding assays indicate that Selank does not directly bind to the classic benzodiazepine binding site on the GABA-A receptor complex, suggesting an alternative, indirect modulatory pathway.
Furthermore, rodent models demonstrate that Selank administration influences monoamine neurotransmitter metabolism. Investigators have observed altered gene expression and synthesis rates of serotonin (5-HT) and its primary metabolite, 5-HIAA, in specific brain structures including the hypothalamus and hippocampus. These combined neurochemical actions make regulatory neuropeptides a compelling subject for research into stress response networks and central neurochemical balance.
Beyond its central nervous system targets, Selank retains functional elements of its parent molecule, tuftsin, which plays a well-documented role in immune response modulation. In vitro studies using rodent splenocytes and peripheral blood mononuclear cells indicate that Selank modulates the expression profile of key cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha).
Additionally, quantitative real-time PCR (qRT-PCR) analyses in animal models reveal that Selank influences the transcription of neurotrophic factors, most notably brain-derived neurotrophic factor (BDNF). By altering BDNF mRNA expression in hippocampal tissue, the compound provides a valuable model for investigating neuroplasticity, dendritic branching, and cellular adaptation under condition-induced cellular stress.
To select the correct research compound for a given experimental paradigm, investigators frequently compare Selank against other synthetic neuropeptides sharing similar enzymatic stability modifications. While Selank derives from tuftsin, compounds such as Semax are derived from adrenocorticotropic hormone (ACTH 4-10) and exhibit distinct primary signaling pathways focused on melanocortin receptors and cholinergic systems.
In experimental models evaluating cognitive signaling and stress response, researchers may compare Selank 10mg alongside Semax 10mg or advanced analogues such as N-Acetyl Semax Amidate. While Selank primarily modulates GABAergic and serotonergic dynamics alongside immune signaling, ACTH-derived analogues predominantly affect neurotrophin synthesis and vascular endothelial factors. Evaluating these related compounds side-by-side allows research teams to map distinct pathways involved in neuroprotection and central nervous system homeostasis.
Establishing rigorous quality control parameters is essential when selecting a Selank 10mg shop. PX1 Research adheres to high-specification analytical standards for every production batch. Purity is validated through Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring that total peptide purity routinely exceeds 99.0%, with residual synthesis side-products precisely quantified.
Identity is independently confirmed using Electrospray Ionization Mass Spectrometry (ESI-MS), verifying that the observed molecular weight matches the theoretical target of 751.9 g/mol. Crucially for cell culture and preclinical assays, our compounds undergo Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below stringent research limits (<0.05 EU/mg), eliminating confounding inflammatory variables from your data.
Proper handling of lyophilized Selank 10mg is vital to maintaining structural integrity and preventing premature peptide degradation. Upon receipt in the laboratory, the sealed vial should be allowed to equilibrate to room temperature before reconstitution to prevent condensation from accumulating on the cake.
Reconstitution should be performed using sterile laboratory-grade diluents such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4), depending on downstream assay requirements. The diluent should be introduced slowly down the inner glass wall of the vial. Avoid vigorous vortexing or aggressive agitation, as shear forces can disrupt peptide tertiary structures; instead, gently swirl the vial until the lyophilized powder is completely dissolved.
Lyophilized Selank 10mg vials remain stable for extended periods when stored at -20°C in a desiccated, dark environment. Exposure to direct light, elevated temperatures, and freeze-thaw cycles accelerates peptide bond hydrolysis and methionine oxidation.
Once reconstituted into an aqueous solution, aliquots should be prepared using sterile microcentrifuge tubes to prevent repeated thermal cycling. Reconstituted liquid samples are typically stable at 2°C to 8°C for short-term experimental series (up to 30 days) or at -80°C for long-term storage. Using dedicated low-protein-binding tubes minimizes non-specific adsorption of the peptide to container walls.
PX1 Research is committed to supplying reliable, highly characterized reference compounds to universities, contract research organizations (CROs), and private biotechnology laboratories. Every lot of Selank 10mg is synthesized in USA-based facilities adhering to GMP-compliant procedures and audited under ISO 17025 laboratory quality management systems.
We recognize that research schedules depend on efficient procurement. PX1 Research maintains centralized inventory in California and Arizona, enabling same-day dispatch for orders placed before cutoff times Monday through Friday. Every shipment includes comprehensive lot traceability and immediate access to analytical certificates of analysis.
For high-throughput screening projects, longitudinal animal studies, or multi-departmental research initiatives requiring bulk quantities of reference peptides, PX1 Research provides streamlined institutional purchasing. Our procurement team works directly with lab managers and purchasing agents to provide customized quotes, volume tier pricing, and scheduled batch reservations.
To explore bulk supply options or integrate PX1 Research into your institution's approved vendor matrix, visit our dedicated wholesale portal or contact our technical support staff to discuss your specific analytical requirements.
What is the primary identity and sequence of Selank 10mg?
Selank is a synthetic heptapeptide derived from the natural immunomodulatory peptide tuftsin. Its primary sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, featuring a C-terminal tripeptide extension engineered to enhance enzymatic resistance in preclinical experimental models.
How is the purity of PX1 Research Selank 10mg verified?
Every lot of Selank 10mg undergoes dual analytical testing via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination and Electrospray Ionization Mass Spectrometry (ESI-MS) for structural identity verification. Certificates of Analysis are publicly accessible for every batch.
What are the endotoxin limits for PX1 Research peptides?
All peptides supplied by PX1 Research undergo LAL (Limulus Amebocyte Lysate) endotoxin testing. Endotoxin levels are verified to be below 0.05 EU/mg, ensuring suitability for sensitive cell culture assays and preclinical animal research.
How should lyophilized Selank 10mg be stored upon arrival?
Lyophilized vials should be stored at -20°C in a dry, dark environment upon arrival. Under these conditions, the peptide maintains analytical stability for up to 24 months.
What is the recommended diluent for reconstituting Selank 10mg?
For standard laboratory handling, sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4) is typically used. The choice of diluent depends on the specific requirements of the downstream in vitro or ex vivo assay protocol.
Can Selank 10mg be used for human consumption or clinical applications?
No. All products offered by PX1 Research, including Selank 10mg, are strictly intended for laboratory research, in vitro assays, and preclinical scientific studies. They are not for human or veterinary use, therapy, or clinical diagnostic procedures.
What central pathways are studied in Selank preclinical literature?
Preclinical literature evaluates Selank primarily for its influence on GABAergic allosteric modulation, serotonergic turnover rates, BDNF gene expression, and peripheral/central cytokine modulation (e.g., IL-6 and TNF-alpha).
Where does PX1 Research ship Selank 10mg orders from?
PX1 Research operates fulfillment facilities located in California and Arizona, providing rapid nationwide shipping with same-day dispatch for qualifying orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.